Scholars@Duke publication: Pre- and Post-Bevacizumab Glioblastoma Histopathology, Biomarkers and Imaging: An Autopsy Study

Pre- and Post-Bevacizumab Glioblastoma Histopathology, Biomarkers and Imaging: An Autopsy Study

Publication , Conference

Muller, K; Farid, N; White, N; McDonald, C; Pizzo, D; Furnari, F; Dale, A; VandenBerg, S

Published in: JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

2013

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

0022-3069

2013

566 / 566

APA

Chicago

ICMJE

MLA

NLM

Muller, K., Farid, N., White, N., McDonald, C., Pizzo, D., Furnari, F., … VandenBerg, S. (2013). Pre- and Post-Bevacizumab Glioblastoma Histopathology, Biomarkers and Imaging: An Autopsy Study. In JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (Vol. 72, pp. 566–566).

Muller, Karra, Nikdokht Farid, Nathan White, Carrie McDonald, Donald Pizzo, Frank Furnari, Anders Dale, and Scott VandenBerg. “Pre- and Post-Bevacizumab Glioblastoma Histopathology, Biomarkers and Imaging: An Autopsy Study.” In JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 72:566–566, 2013.

Muller K, Farid N, White N, McDonald C, Pizzo D, Furnari F, et al. Pre- and Post-Bevacizumab Glioblastoma Histopathology, Biomarkers and Imaging: An Autopsy Study. In: JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2013. p. 566–566.

Muller, Karra, et al. “Pre- and Post-Bevacizumab Glioblastoma Histopathology, Biomarkers and Imaging: An Autopsy Study.” JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, vol. 72, no. 6, 2013, pp. 566–566.

Muller K, Farid N, White N, McDonald C, Pizzo D, Furnari F, Dale A, VandenBerg S. Pre- and Post-Bevacizumab Glioblastoma Histopathology, Biomarkers and Imaging: An Autopsy Study. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2013. p. 566–566.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

0022-3069

2013

566 / 566